Schizophrenia: Recent Advances in Diagnosis and Treatment

ISBN-13: 9781493906550 / Angielski / Twarda / 2014 / 331 str.

Philip G. Janicak; Stephen R. Marder; Rajiv Tandon

Opis

Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change. The book is divided into five sections. Section 1 summarizes the present state of knowledge about the diagnosis and treatment of schizophrenia. This includes recent changes in the DSM 5 categorization of schizophrenia and its implications for treatment. Section 2 considers recent discoveries into its pathoetiology, including the status of biological markers, genetics and neuroimaging as they relate to diagnosis and potential novel therapeutic approaches. Section 3 explores the optimization of present therapeutic approaches; novel treatments; and management of the substantial risks associated with both the illness and its present therapies. Section 4 discusses progress in the long-term management of schizophrenia, focusing on biological and psychotherapeutic strategies to improve functioning and facilitate recovery. Section 5 considers future directions and predictions of how diagnosis and treatment of schizophrenia will change. An invaluable addition to the field, Schizophrenia: Recent Advances in Diagnosis and Treatment is a definitive resource that will be of great interest to all clinicians caring for patients with schizophrenia.

Recenzje

"The book reviewed deals with the aforementioned problems; the evolving nosology of schizophrenia relevance for treatment, recent research of pathophysiology, medical management of schizophrenia, its long term complications and future directions and implications. I believe this book is going to be of great help for all the clinicians and the researchers involved in the interesting and demanding field of managing schizofrenia." (Assist. Prof. Branka Vidrih, Alcoholism and Psychiatry Research, Vol. 51 (2), 2015)

"The book is written for those who are active in the field of schizophrenia and who wish to gain an overall understanding of current research progress across the various modalities of study. ... This is an excellent book that would be quite useful to anyone looking for an overview of the progress in Schizophrenia to date. It is a solid addition to the literature." (Sean D. Conrin, Doody's Book Reviews, August, 2014)

Spis treści

Section 1: Overview

 

1.      Introduction

Philip G. Janicak, Stephen R. Marder, Rajiv Tandon and Morris B. Goldman

     

2.      The Evolving Nosology of Schizophrenia: Relevance for Treatment

Rajiv Tandon and Dawn M. Bruijnzeel

 

Section 2: Recent Research into the Pathophysiology of Schizophrenia

 

3.      Overview of Neurobiology

Rajiv Tandon and Morris B. Goldman

 

4.      Pathophysiology of Schizophrenia

Jaya Padmanabhan and Matcheri S. Keshavan

 

5.      Genetics of Schizophrenia

Alan R. Sanders

 

6.      Recent Advances in Neuroimaging Biomarkers of Schizophrenia

Lei Wang and John G. Csernansky

 

Section 3: Medical Management of Schizophrenia

 

7.      Acute Management of  Schizophrenia

Philip G. Janicak

 

8.      Therapeutic Neuromodulation for Treatment of Schizophrenia

Jeffrey T. Rado and Edgar I. Hernandez

 

9.      Pharmacogenetics in the Treatment of Schizophrenia

Bill W. Massey, Jiang Li, and Herbert Y. Meltzer

 

10.  Management of Comorbid Medical Conditions in Schizophrenia

Jeffrey T. Rado

 

11.  Management of Water Imbalance in Schizophrenia

Morris B. Goldman and Pichai Ittasakul

 

12.  Management of Medication-Related Adverse Effects

Wanlop Atsariyasing and Morris B. Goldman

 

Section 4: Management of Schizophrenia and its Long-Term Complications

­

13.  Long-Term Pharmacological Management of Schizophrenia

Stephen R. Marder

 

14.  Psychosocial Rehabilitation and Psychotherapy Approaches

Robert S. Kern ,William P. Horan, Shirley M. Glynn, L. Felice Reddy, Jason Holden, Eric Granholm, Luana R. Turner, Mary E. Sullivan and William D. Spaulding

 

Section 5: Future Directions and Implications

 

15.   Conclusion

Philip G. Janicak, Stephen R. Marder, Rajiv Tandon, and Morris B. Goldman

 

O autorze

Philip G. Janicak, M.D. Professor of Psychiatry Rush University Chicago, IL Stephen R. Marder, M.D. Professor and Director, Section on Psychosis Semel Institute at UCLA Director, Desert Pacific Mental Illness Research, Education, and Clinical Center VA Greater Los Angeles Healthcare Center Los Angeles, CA Rajiv Tandon, M.D. Professor of Psychiatry, University of Florida College of Medicine Chief of Psychiatry, North Florida/South Georgia V.A. Healthcare System University of Florida College of Medicine Gainesville, FL Morris Goldman, M.D. Associate Professor of Psychiatry Northwestern University Department of Psychiatry Chicago, IL.